The agency keeps the manufacturing decree active and the pharmaceutical company’s president continues to benefit from the resident investor decree
The agency keeps the manufacturing decree active and the pharmaceutical company’s president continues to benefit from the resident investor decree
August 30, 2024 - 12:01 PM
Problems in the operation of the biopharmaceutical company Romark Global Pharma in Puerto Rico allegedly began some five years ago, causing, among other things, the Department of Economic Development and Commerce (DDEC) to cancel contracts that provided economic assistance to the company, confirmed Soraya Morón, assistant secretary of Entrepreneurship and Business Development of the DDEC.
Las noticias explicadas de forma sencilla y directa para entender lo más importante del día.
Te invitamos a descargar cualquiera de estos navegadores para ver nuestras noticias: